All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @popethecoach on TikTok · 43s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @popethecoach's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00TRT update week 10 part 2. So some of you know that I switched to an online clinic and I just had
  2. 0:05one of my first consultations after getting my labs done. Good news is our levels went up to
  3. 0:09974. Bad news is it's at 974 the day after pinning. Yes, I know I should have waited longer to do my
  4. 0:16labs. But this also gave me a good indication. After discussing it with one of the nurse practitioners,
  5. 0:21they ended up saying that I will be increasing my dosage from 160 milligrams a week to 200 milligrams
  6. 0:26a week. I'm still going to be pinning intramuscular but this time I'm going to be doing 100 milligrams
  7. 0:31on Monday and Thursday. That should optimize my levels a little bit better as well as optimize
  8. 0:35the energy that I'm lacking. So if you're an expert or a beginner on TRT, leave any advice or
  9. 0:40any questions you have over in the comments and I hope you'll have a great day.

Online TRT clinics vs. traditional care: what the evidence shows

Pope | The Coach

TikTok creator

9.5K viewsWatch on TikTok

Quick answer

The creator is 10 weeks into testosterone cypionate therapy, currently at 160 mg per week via intramuscular injection. His reported lab value of 974 ng/dL was drawn approximately 24 hours post-injection, which reflects a near-peak level rather than a clinically meaningful trough, making the result unreliable for guiding dose titration. His clinic increased his dose to 200 mg per week split as 100 mg twice weekly based on this data, alongside subjective complaints of low energy.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Online TRT clinics vs. traditional care: what the evidence shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Online TRT clinics vs. traditional care: what the evidence shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Online TRT clinics vs. traditional care: what the evidence shows" from Pope | The Coach. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is 10 weeks into testosterone cypionate therapy, currently at 160 mg per week via intramuscular injection.

The reason this review is not generic is the source wording and the canonical claim label "trt swapping to an online clinic was the best decision i made si." In this clip, the useful excerpt is: "TRT update week 10 part 2." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Peak testosterone levels after intramuscular cypionate occur 24-72 hours post-injection per Bhasin et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is 10 weeks into testosterone cypionate therapy, currently at 160 mg per week via intramuscular injection.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is 10 weeks into testosterone cypionate therapy, currently at 160 mg per week via intramuscular injection. His reported lab value of 974 ng/dL was drawn approximately 24 hours post-injection, which reflects a near-peak level rather than a clinically meaningful trough, making the result unreliable for guiding dose titration. His clinic increased his dose to 200 mg per week split as 100 mg twice weekly based on this data, alongside subjective complaints of low energy.
  • Trough timing matters: the Endocrine Society's 2018 guidelines recommend drawing testosterone labs immediately before the next scheduled injection to get a clinically meaningful result.
  • Peak testosterone levels after intramuscular cypionate occur 24-72 hours post-injection per Bhasin et al. (2010, JCEM), meaning a same-day or next-day draw overstates your functional hormone levels.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Trough timing matters: the Endocrine Society's 2018 guidelines recommend drawing testosterone labs immediately before the next scheduled injection to get a clinically meaningful result.
  • Peak testosterone levels after intramuscular cypionate occur 24-72 hours post-injection per Bhasin et al. (2010, JCEM), meaning a same-day or next-day draw overstates your functional hormone levels.
  • Twice-weekly injection splits do reduce peak-to-trough variability and are supported by pharmacokinetic data reviewed in Schulster et al. (2016, Reviews in Urology), independent of total dose.
  • A 25% dose increase from 160 mg to 200 mg weekly is a meaningful change that warrants a correctly timed trough lab before, not after, the adjustment is made.
  • Low energy on TRT does not automatically mean low testosterone. Thyroid function, sleep quality, cortisol, and iron status should all be considered before attributing fatigue solely to hormone levels.
  • If your telehealth provider does not ask when you last injected before interpreting your lab results, that is a protocol gap worth raising directly with your prescriber.
  • Target range for trough testosterone in most clinical guidelines sits around 400-700 ng/dL, not the peak values that get reported when testing is mistimed.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @popethecoach actually say?

At week 10 of TRT, @popethecoach reported a testosterone level of 974 ng/dL, then immediately flagged the problem himself: the blood draw happened "the day after pinning." His clinic increased his weekly dose from 160 mg to 200 mg, split into two injections of 100 mg on Monday and Thursday. He expects this to fix his energy issues.

To his credit, he caught his own methodological error before anyone else could. Testing 24 hours after an injection of testosterone cypionate captures peak or near-peak serum levels, not trough. That number tells you very little about where your levels actually sit when the hormone is doing its day-to-day work. The problem is that his clinic may have made a dosing decision based on exactly that misleading number.

Does the science back this up?

The timing issue here is not minor. It is the whole ballgame. Peak serum levels after intramuscular testosterone cypionate typically occur 24-72 hours post-injection, according to pharmacokinetic data reviewed by Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism). Trough levels, drawn immediately before the next scheduled injection, are the standard reference point used to assess whether a protocol is actually working.

A 974 ng/dL reading at peak looks fine on paper. Normal male reference range is roughly 300-1000 ng/dL, though some labs cap at 1100. But if his trough is sitting at, say, 400 ng/dL, that is a very different clinical picture than a trough of 700 ng/dL. Splitting the dose into twice-weekly injections, as his nurse practitioner recommended, is genuinely well-supported by the evidence. Research by Schulster et al. (2016, Reviews in Urology) confirms that more frequent dosing reduces peak-to-trough fluctuation and improves symptom stability. That part of the advice was sound.

What did they get wrong (or right)?

@popethecoach got the self-awareness part right. Admitting on camera that his lab timing was off takes honesty, and it should prompt anyone watching to think harder about their own testing protocols. That transparency is useful.

What is harder to defend is the clinic's decision to increase his dose based on this data. A responsible protocol would typically request a repeat trough draw before adjusting dosage upward. Moving from 160 mg to 200 mg per week is a 25% increase. Without a valid trough measurement, you do not know whether the current dose is actually insufficient or whether the patient simply tested at the wrong time. The Endocrine Society's 2018 clinical practice guidelines for male hypogonadism explicitly recommend measuring trough levels, specifically drawing blood just before the next injection, to guide dose adjustments. Attributing low energy to suboptimal testosterone levels is also a leap. Energy complaints have a long differential, including sleep quality, thyroid function, cortisol, and iron status, none of which were mentioned here.

What should you actually know?

If you are on TRT and getting labs done, trough timing is non-negotiable for making sense of your numbers. Draw blood on the morning of your next scheduled injection, before you inject. Anything else gives you a snapshot that could push your provider toward an unnecessary dose increase, which carries real risks including elevated hematocrit, suppressed fertility, and cardiovascular strain over time.

The twice-weekly split @popethecoach is moving to is a reasonable protocol adjustment on its own merits, supported by pharmacokinetic logic. But that change should be evaluated with correctly timed labs. The Endocrine Society guidelines recommend targeting mid-normal physiologic range, roughly 400-700 ng/dL at trough for most men, not chasing peak numbers. If you are working with a telehealth clinic, ask specifically whether your lab order specifies trough timing. If they do not ask when you last injected before interpreting your results, that is a red flag worth raising directly.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Pope | The Coach · TikTok creator

9.5K views on this video

Swapping to an online clinic was the best decision I made since being in TRT 😮‍💨 #trt #lowtestosterone #trtcommunity #trtfamily #testosteronetherapy #fyp #viral

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about trough timing matters: the endocrine society's 2018 guidelines recommend drawing?

Trough timing matters: the Endocrine Society's 2018 guidelines recommend drawing testosterone labs immediately before the next scheduled injection to get a clinically meaningful result.

What does the video say about peak testosterone levels after intramuscular cypionate occur 24-72 hours post-injection?

Peak testosterone levels after intramuscular cypionate occur 24-72 hours post-injection per Bhasin et al. (2010, JCEM), meaning a same-day or next-day draw overstates your functional hormone levels.

What does the video say about twice-weekly injection splits do reduce peak-to-trough variability?

Twice-weekly injection splits do reduce peak-to-trough variability and are supported by pharmacokinetic data reviewed in Schulster et al. (2016, Reviews in Urology), independent of total dose.

What does the video say about a 25% dose increase from 160 mg to 200 mg?

A 25% dose increase from 160 mg to 200 mg weekly is a meaningful change that warrants a correctly timed trough lab before, not after, the adjustment is made.

What does the video say about low energy on trt does not automatically mean low testosterone.?

Low energy on TRT does not automatically mean low testosterone. Thyroid function, sleep quality, cortisol, and iron status should all be considered before attributing fatigue solely to hormone levels.

What does the video say about if your telehealth provider does not ask?

If your telehealth provider does not ask when you last injected before interpreting your lab results, that is a protocol gap worth raising directly with your prescriber.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Pope | The Coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.